Trending Articles

article thumbnail

Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn

Pharmaceutical Technology

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the strong growth potential of Japans healthcare industry.

262
262
article thumbnail

AbbVie, Pfizer gain FDA OK for novel antibiotic

Bio Pharma Dive

The drug is cleared to treat complicated intra-abdominal infections, including those caused by tough-to-control, gram-negative bacteria.

Bacteria 248
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Vertex challenger Sionna prices $191M IPO

Bio Pharma Dive

The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or be used in new, multi-drug combinations.

Medicine 281
article thumbnail

A Type of Fiber Could Have Weight Loss Benefits Similar to Ozempic

AuroBlog - Aurous Healthcare Clinical Trials blog

(courtneyk/Getty Images) Research on the gut microbiome has triggered a ‘revolution‘ in nutritional science, and in the last few years, dietary fiber has become the “new protein” added to foods in abundance to feed our gut and boost our health. A recent study on mice, however, suggests not all fiber supplements are equally beneficial.

Protein 223
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

February 12, 2025: Results of ACP PEACE, an NIH Collaboratory Trial, in This Week’s PCT Grand Rounds

Rethinking Clinical Trials

In this Friday’s PCT Grand Rounds, Angelo Volandes of Dartmouth Health and James Tulsky of Dana-Farber Cancer Institute will present “A Cluster Randomized, Stepped-Wedge Pragmatic Trial to Enhance Goals-of-Care Communication for Older Adults With Cancer (ACP-PEACE).” The Grand Rounds session will be held on Friday, February 14, 2025, at 1:00 pm eastern.

Trials 148
article thumbnail

Scientists discover mitochondria's role in shaping memory circuits

Medical Xpress

Virginia Tech neuroscientists have uncovered a mitochondrial process that supports the brain cells critical for learning, memory, and social recognition.

Scientist 141

More Trending

article thumbnail

Revealed: How Much Exercise You Need to ‘Offset’ a Day of Sitting

AuroBlog - Aurous Healthcare Clinical Trials blog

(Jack Atkinson/Unsplash) We know that spending lots of time sitting down isn’t good for us, but just how much exercise is needed to counteract the negative health effects of sitting down all day? Research suggests about 30-40 minutes per day of building up a sweat should do it.

Research 218
article thumbnail

Capgemini unveils AI breakthrough to boost bioeconomy

Pharma Times

New methodology may boost innovation in protein engineering

Engineer 128
article thumbnail

Mitochondria's role in diabetes: Could reversing damage offer a cure?

Medical Xpress

Mitochondria are essential for generating energy that fuels cells and helps them function.

Research 131
article thumbnail

Bristol Myers gives first peek at closely watched launch of schizophrenia drug

Bio Pharma Dive

Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and is around 1,000 prescriptions weekly by late January.

Sales 248
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Fourth person receives eGenesis’ gene-edited pig kidney transplant

Pharmaceutical Technology

Tim Andrews underwent the procedure with the pig kidney as part of a three-person compassionate use study.

article thumbnail

Can a Supplement Really Help You Control Your Pesky Eye Floaters?

AuroBlog - Aurous Healthcare Clinical Trials blog

(Filipp Romanovski/Unsplash) If you look up at the sky on a clear day, you might notice little cobweb-like structures drifting across your field of vision.

article thumbnail

Hemgenix shows efficacy among haemophilia B patients

Pharma Times

CSL Behring's study reveals significant long-term benefits

114
114
article thumbnail

Scientists peel away the mystery of JAK enzymes, which play roles in everything from eczema to ulcerative colitis

Medical Xpress

Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of medications called JAK inhibitors, using an acronym that assumes the average TV watcher knows exactly what JAK stands for.

Scientist 129
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

GSK, Pfizer sales of RSV shots slow as vaccination rates ebb

Bio Pharma Dive

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

Sales 219
article thumbnail

Novartis signs agreement to acquire Anthos for $925m upfront

Pharmaceutical Technology

Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront payment of $925m.

207
207
article thumbnail

Radical Study Proposes a Single Cause to Explain Alzheimer’s Disease

AuroBlog - Aurous Healthcare Clinical Trials blog

(koto_feja/E+/Getty Images) A new model of Alzheimer’s disease has been proposed, which could speed up efforts to understand and cure the complex condition while bringing all manifestations of the condition under one unifying theory.

RNA 130
article thumbnail

Grand Rounds January 31, 2025: Advancing Rural Back Pain Outcomes Using Rehabilitation Telehealth (ARBOR-Telehealth): Early Progress and Lessons Learned (Richard L. Skolasky, ScD; Kevin H. McLaughlin, DPT)

Rethinking Clinical Trials

Speakers Richard L. Skolasky, ScD Professor, Johns Hopkins School of Medicine Department of Orthopaedic Surgery Kevin H. McLaughlin, DPT Assistant Professor, Johns Hopkins School of Medicine Department of Physical Medicine and Rehabilitation Slides Keywords Back Pain; Rural Health; Telehealth Key Points Low back pain (LBP) is the most common cause of disability globally and in the U.S.

Medicine 100
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Flu season in the US is the most intense it's been in at least 15 years

Medical Xpress

The U.S. winter virus season is in full force, and by one measure is the most intense in 15 years.

111
111
article thumbnail

Axsome secures top drug’s future with Teva patent settlement

Bio Pharma Dive

Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy of Auvelity from entering the U.S. market until at least 2038.

Marketing 180
article thumbnail

Super Bowl ad for copycat weight loss drugs stokes pharma power debate

Pharmaceutical Technology

Controversy surrounded Him & Hers commercial, called Sick of the System, in the lead up to Americas biggest sporting event.

Drugs 205
article thumbnail

India needs to develop strategies to mitigate the impact of USAID funding freeze

AuroBlog - Aurous Healthcare Clinical Trials blog

Indian pharmaceutical industry plays a crucial role in the global drug supply chain, particularly in the US. Yet India needs to develop strategies to mitigate the impact of USAID funding freeze for Indian pharma companies.

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Novartis secures MHRA authorisation for ribociclib

Pharma Times

Breast cancer therapy offers hope for patients at risk of recurrence

103
103
article thumbnail

Human breast milk found to enhance corneal healing in new research

Medical Xpress

Years ago, a young patient's mother told Emily McCourt, MD, associate professor of ophthalmology at the University of Colorado School of Medicine, that she hadn't used a prescribed ointment to treat her baby's chemical corneal burn but instead used her own breast milk.

Research 111
article thumbnail

Novo outlines new late-stage study of obesity drug CagriSema

Bio Pharma Dive

CagriSema, which underperformed expectations in its first Phase 3 test, will be studied at different doses and for longer duration in the new trial.

Drugs 180
article thumbnail

WHO and St Jude start distributing paediatric cancer medicines amid US aid cuts

Pharmaceutical Technology

The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer medicines to LMICs.

Medicine 200
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

FDA clears new antibiotic for superbug infections

pharmaphorum

AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.

article thumbnail

FDA grants Orphan Drug Designation to Ariceum cancer therapy

Pharma Times

Designation follows promising preclinical data and FDA clearance

Drugs 80
article thumbnail

Brain cells mimic muscle signaling to enhance learning and memory

Medical Xpress

New research details the subcellular structures in neurons that enable signals to be transmitted from where they are received at specific sites on dendrites to the decision-making cell body located hundreds of micrometers away. The new research finds that the endoplasmic reticulum and the plasma membrane form contact sites where specialized molecules control the release of calcium, which regulates the signals sent along the dendrite to the soma.

article thumbnail

Novartis pays $925M to reel in a startup it helped launch

Bio Pharma Dive

The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed to the Blackstone-backed startup six years ago.

Licensing 173
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.